The drug diazaborine blocks ribosome biogenesis by inhibiting the AAA-ATPase Drg1.
The drug diazaborine is the only known inhibitor of ribosome biogenesis and specifically blocks large subunit formation in eukaryotic cells. However, the target of this drug and the mechanism of inhibition were unknown. Here we identify the AAA-ATPase Drg1 as a target of diazaborine. Inhibitor binding into the second AAA ... domain of Drg1 requires ATP loading and results in inhibition of ATP hydrolysis in this site. As a consequence the physiological activity of Drg1, i.e. the release of Rlp24 from pre-60S particles, is blocked, and further progression of cytoplasmic preribosome maturation is prevented. Our results identify the first target of an inhibitor of ribosome biogenesis and provide the mechanism of inhibition of a key step in large ribosomal subunit formation.
Mesh Terms:
Adenosine Triphosphatases, Adenosine Triphosphate, Binding Sites, Boron Compounds, Cytoplasm, Enzyme Inhibitors, Ribosomal Proteins, Ribosome Subunits, Large, Eukaryotic, Saccharomyces cerevisiae, Saccharomyces cerevisiae Proteins
Adenosine Triphosphatases, Adenosine Triphosphate, Binding Sites, Boron Compounds, Cytoplasm, Enzyme Inhibitors, Ribosomal Proteins, Ribosome Subunits, Large, Eukaryotic, Saccharomyces cerevisiae, Saccharomyces cerevisiae Proteins
J. Biol. Chem.
Date: Feb. 14, 2014
PubMed ID: 24371142
View in: Pubmed Google Scholar
Download Curated Data For This Publication
182463
Switch View:
- Interactions 13